HK2 and acute myeloid leukemia: In chemoresistant AML cells, internal tandem duplication mutation in the FLT3 (Fms-like tyrosine kinase 3) gene leads to the hyper-expression of HK2 and increased glycolytic flux, which makes the leukemic cells sensitive to glycolysis inhibitors [7].